The Japanese orthopedic biomaterials market is expected to approach $1.5 billion by 2019. The hyaluronic acid viscosupplementation segment is expected to constitute the majority of the Japanese orthopedic biomaterials market. The orthopedic biomaterials market comprises autologous bone grafts, bone graft substitutes (segmented only into synthetics) and hyaluronic acid (HA) viscosupplementation. Although the market has reached maturity in Japan, it is expected to continue to grow as a result of the large aging population. Further growth in the overall market will be fuelled by the increased value of the HA viscosupplementation segment. This is due to the continued use of premium …
Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=103722.
Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/japanese-orthopedic-biomaterials-market-market-report.html.
No comments:
Post a Comment